GLP Watchdog

altRX vs Fridays

altRX has an open FDA warning letter dated June 8, 2026. Fridays has none. On brand-name tirzepatide pen, altRX costs $6,948 less a year at standing rates: $1,249 a month against $1,828 a month at Fridays. It is one of four products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

altRX / Fridays

Featured pick (affiliate partner)

altRX logo

altRX

8.8/10

Fridays logo

Fridays

5.8/10

FDA warning letters
None on record
Pharmacy
  • RedRock Pharmacy503A
  • Health Warehousetype not stated
  • Precision Medicinetype not stated
  • and 1 more
Lowest standing price
$89/moCompounded semaglutide injection
$249/moCompounded semaglutide injection
States
All 50 states
No state list published
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit altRX
Visit Fridays

altRX is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Fridays pays us nothing. The scores are computed the same way for both and are shown as computed (altRX 8.8, Fridays 5.8). How we are paid

What the record shows

  1. 01

    altRX has an open FDA warning letter dated June 8, 2026. Fridays has none.

  2. 02

    altRX names four pharmacies. Fridays names four pharmacies.

  3. 03

    On brand-name tirzepatide pen, altRX costs $6,948 less a year at standing rates: $1,249 a month against $1,828 a month at Fridays. It is one of four products the two sell at comparable terms.

  4. 04

    altRX lists all 50 states. Fridays publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

altRX

Fridays

Compounded semaglutide injection

$89/moLower

$1,068 a year

$249/mo

$2,988 a year

Compounded tirzepatide injection

$149/moLower

$1,788 a year

$359/mo

$4,308 a year

Brand-name semaglutide pen

$1,149/moLower

$13,788 a year

$1,498/mo

$17,976 a year

Brand-name tirzepatide pen

$1,249/moLower

$14,988 a year

$1,828/mo

$21,936 a year

Price includes
Medication, clinician visits, shipping
Medication, clinician visits, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the monthly plan; multi-month plans are prepaid and non-refundable
None on the monthly plan; 3, 6 and 12-month plans are prepaid
Refunds
All payments are final and non-refundable, except a partial refund if you are medically disqualified
Fees are non-refundable except for medical disqualification, billing errors or where the law requires

Read off each seller’s own pages. altRX: September 28, 2026. Fridays: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for altRX

8.8/10
Featured pick (affiliate partner)
  • $1,920 a year less on compounded semaglutide injection
  • $2,520 a year less on compounded tirzepatide injection
  • Open FDA warning letter, June 8, 2026
Visit altRX

The case for Fridays

5.8/10
  • No FDA warning letter on record
  • Publishes no state list
Visit Fridays

Scores

altRX 8.8 · Fridays 5.8 out of 10. Six weighted parts.

Value25%

10.0A
vs
B
3.4

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

6.0A
vs
B
5.5

Accessibility10%

10.0A
vs
B
5.0

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

altRX vs Fridays: questions

altRX has an open FDA warning letter dated June 8, 2026. Fridays has none. Letters are matched to a seller by company, domain and address, never by a similar name.
altRX names four pharmacies. Fridays names four pharmacies. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
altRX, by $1,920 a year at standing rates. altRX: $89 a month, about $1,068 a year. Fridays: $249 a month, about $2,988 a year.
altRX states you can cancel at any time; refunds: all payments are final and non-refundable, except a partial refund if you are medically disqualified. Fridays states you can cancel at any time; refunds: fees are non-refundable except for medical disqualification, billing errors or where the law requires.
altRX is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Fridays pays us nothing. The scores are computed the same way for both and are shown as computed (altRX 8.8, Fridays 5.8).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks